| (210) | Number of the EPO application | 16800846 |
| (220) | Filing date of the EPO application | 2016.05.27 |
| (80) | EPO patent specification publication (B) | EPB nr. 08/2023, 2023.02.22 |
| (110) | EPO patent number | 3302507 |
| (21) | Number of the application | e 2018 0358 |
| (71) | Name(s) of applicant(s), code of the country | The United States of America, as represented by
The Secretary, Department of Health and Human
Services, US;
Kite Pharma, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | BOT Adrian, US;
WIEZOREK Jeffrey S., US;
GO William, US;
JAIN Rajul, US;
KOCHENDERFER James N., US;
ROSENBERG Steven A., US; |
| (73) | Name(s) of owner(s), code of the country | The United States of America, as represented by
The Secretary, Department of Health and Human
Services, US;
Kite Pharma, Inc., US; |
| (54) | Title of the invention | DIAGNOSTIC METHODS FOR T CELL THERAPY |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 35/17 (2015.01.01); A61K 38/20 (2006.01.01); C12N 5/0783 (2010.01.01); C12N 5/10 (2006.01.01); C12N 15/19 (2006.01.01); C12N 15/24 (2006.01.01); A61K 31/00 (2006.01.01); C07K 14/52 (2006.01.01); C07K 14/00 (2006.01.01); C12N 15/00 (2006.01.01); G01N 33/68 (2006.01.01); A61P 35/00 (2006.01.01); A61K 31/095 (2006.01.01); A61K 31/445 (2006.01.01); A61K 31/52 (2006.01.01); A61K 31/665 (2006.01.01); A61K 39/00 (2006.01.01); C07K 14/725 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.05.31 |
| (30) | Priority | 201562167738 P, 2015.05.28, US; 201562262111 P, 2015.12.02, US |
| (86) | International application | PCT/US2016/034885, 2016.05.27 |
| (87) | International publication | WO 2016/191755, 2016.12.01 |